Comparsion of Flow Cytometric and Alamar Blue Tests with the Proportional Method for Testing Susceptibility of Mycobacterium tuberculosis to Rifampin and Izoniazid

Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro. Instituto de Microbiologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.

Resumo em Inglês

The performance of flow cytometry and the microplate Alamar Blue assay in determining susceptibility of Mycobacterium tuberculosis was assessed by testing 150 Brazilian isolates. The overall agreement was 97.3 and 98% for isoniazid and 94.7 and 100% for rifampin by flow cytometry and MABA, respectively. This study was entirely done in a developing country.

Palavras-chave em inglês

Antitubercular Agents
Isoniazid
Microbial Sensitivity Tests
Mycobacterium tuberculosis
Oxazines
Rifampin
Xanthenes

Editor

American Society for Microbiology

Referência

REIS, Roberto S. et al. Comparison of flow cytometric and Alamar Blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid. Journal of Clinical Microbiology, v. 42, n. 5, p. 2247-2248, 2004.

DOI

10.1128/jcm.42.5.2247-2248.2004

ISSN

0095-1137

Use este identificador para citar ou linkar para este item: https://www.arca.fiocruz.br/handle/icict/42410

Tipo de documento

Direito Autoral

Acesso aberto

Coleções

Compartilhar

Estatísticas

Metadata

Autor(es)

Afiliação